Kwality Pharmaceuticals Limited (BOM:539997)

Market Cap	9.86B
Revenue (ttm)	3.70B
Net Income (ttm)	398.45M
Shares Out	10.38M
EPS (ttm)	38.36
PE Ratio	24.77
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,071
Average Volume	26,659
Open	936.55
Previous Close	948.90
Day's Range	926.00 - 957.75
52-Week Range	481.00 - 1,069.95
Beta	-0.35
RSI	67.41
Earnings Date	May 30, 2025

About Kwality Pharmaceuticals

Kwality Pharmaceuticals Limited, together with its subsidiary, manufactures, buys, sells, and deals finished pharmaceutical formulations in India and internationally. It offers its products in various dosage forms, including liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments/cream, external preparations, ORS, eye/ear drops, sanitizers, suppositories, injectable vials and ampoules, lyophilized and covid products, syrups, daunorubicin, and other various categories, such ...

• Industry: Pharmaceutical Preparations
• Founded: 1983
• Employees: 806
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539997

Financial Performance

In 2024, Kwality Pharmaceuticals's revenue was 3.70 billion, an increase of 20.52% compared to the previous year's 3.07 billion. Earnings were 398.45 million, an increase of 67.44%.